Diverticular Disease Market Research Report - Forecast to 2030

Diverticular Disease Market Research Report: Type (Diverticulosis, Diverticulitis) Treatment (Medication, Supportive Care, Surgery) Diagnosis (CT Scan, Ultrasound, Urine Test, Blood Test) End User (Hospitals, Specialty Centers) ‚Äď Forecast till 2030

ID: MRFR/Pharma/4239-HCR | | Region: Global | 105 Pages         

Diverticular Disease Market Speak to Analyst Request a Free Sample

Diverticular Disease Market Overview


The diverticular disease market has been expected to make growth in a healthy way with a CAGR rate of 7.8% by 2030. Diverticular disease has a digestive condition and that leads to the better formation of the small budges or sacs in the wall of the large intestine.  Apart from that, the sacs have been formed in between the colon and also have been found in between the sigmoid colon as well. According to the market scenario, approximately 962 million population has been aged over 60. Therefore, the rising aging analysis of the population has been likely to make the growth of the Diverticular disease market.  Further, to this scenario, the market has been majorly driven by the growing demand of the prevalence of obesity and that includes the rising population as well. Hence, these additional factors advance treatment as well as offers the growth of the market players with newer products as well. Therefore, an estimation of 2.5 million people has been suffering from the foremost gastrointestinal conditions. Hence, the overview scenario of the market has been under conventional treatment and it focuses on the diagnosis involvement also.


Covid 19 Analysis


Covid 19 is known as an infectious disease and its impact on the global market has been negative. Therefore, the highly contagious disease mainly includes the severe acute syndrome of respiratory issues, and thus, there has been a complete lockdown in the whole world for stopping the situation. Therefore, the sudden outbreak of the disease has affected almost 213 countries and in the public health emergency, it has a huge negative impact. The pharmaceutical along with the biotech companies has come together with the government and have been working to address the outbreak of the Covid19 situation. Therefore, the pharmaceutical and biotechnology industries have been expecting to make significant growth owning a demand for the treatment. The high demands for the drugs have actually presented a huge opportunity for the manufacturers of managing the covid 19 vaccines.


Diverticular Disease Market Dynamics



  • Drivers


One of the most top impacting driving factors states the increase in the prevalence expectation to have a growth in the market. In addition to this sentence, the surge in the geriatric population leads to the rise within the patient population that boosts up the diverticular disease market.  Therefore, the demand for medicines for better treatment has been projected under the global diverticular market.  It has been majorly driven by the rising demand for advanced treatment, the growing population of cigarette smokers, and the growing mass of the young population towards the sedentary lifestyle.



  • Restraints


In this section, one of the restraining factors of the diverticular disease market has been the continuous trial of clinic treatment of rare diseases. A lack of patient awareness attempts to subjectify the developing FDA guidelines for the latest approval of the treatment. It also states that a rise in the number of market players has been offering more products that estimate the growth of the market.



  • Opportunities


One of the basic opportunities of the market exclaims the increase in the sedentary lifestyle with a rise to the gastrointestinal augments in the global market analysis. This tends to improve the healthcare infrastructure with a propel to the DDM. henceforth, new products launched have been considered as an opportunist factor to flourish more globally. Henceforth, the result of flourished products has intended to make the continuation of the R&D development process manually.



  • Challenges


One of the challenging factors of the DDM states the rise in the case of drug intake and obesity. The specific reason behind the diverticular notes is the smoking of cigarettes, lack of exercise, and a diet that is high on animal fat. Hence, all these elements have estimated yo make boost the market. On the other hand, excessive use of certain medications such as opioids, NSAIDs, and steroids has also been considered as one of the challenging factors for the growth of the diverticular disease market.


Cumulative Analysis


The Compound Annual Growth Rate (CAGR) is predicted to grow at 7.5%. Accordingly, the diverticular disease market growth has expanded within the forecast period. Various drivers such as the growing awareness of the treatment as well as the growing demand for medicines for the diseases. This has helped in the rising industrialization of the globe. 


Value Chain Analysis


An increasing emphasis on creating small badges or sacs has given a rise in the market. Hence, this has contributed to the overall impact on the market positively. Also, the growing initiatives by the government for the development and research will improve the value chain of the Diverticular disease Market in the upcoming years.


Diverticular Disease Market Segmentation


According to the overall market growth, the segmentation of the market has been based upon the type, diagnosis, treatment, and end-user. Therefore, on the basis of treatment, the market has been segmented under medications, supportive care as well as surgery. The medication segment has been further segmented under antibiotics, dietary supplements, and penicillin antibiotics for the better classification of the market.


Based on the type, the market has been segmented under diverticulosis, diverticular bleeding, and diverticulitis. On the other hand, based on diagnosis, the stated market has been segmented under the barium X-ray, CT-scan, Liver function test, stool test, blood test, and ultrasound. Lastly, based on end-user, the market has been segmented into hospitals, specialty centers, research centers, and hospitals.


Diverticular Disease Market Regional Analysis


According to the regional analysis of the globe, the market of diverticular disease market has been growing at a pace. Therefore, North America is segmented on a regional basis and it claims the increased number of passive smokers, rise in the older population of the people. Europe has been considered as the second-largest market that holds the healthy share within the diverticular disease market. Additionally, it has been analyzed that the growing expenditure on healthcare facilities and the rise in the demand for technological treatment have been advanced. The European market has been expected to make healthy CAGR during the forecast period that avails the growing need of the market. A rise in the older population, as well as the growing inclination towards a lifestyle, has been the major factor driving the growth. Lastly, Asia-Pacific has been expected to be considered as one of the fastest-growing markets that increases the prevalence of chronic diseases. Apart from that, China has been analyzed as the fastest region with high growth and also owning to the increased population. Therefore, the rising awareness along with the availability of the new treatment method has been driving the growth of the market within the region.


Diverticular Disease Market Competitive Landscape


The diverticular device market comprises moderate competition and it initiates the importance of the several major players that competes with the market. Hence, some of the major key players are:



  • Sucampo Pharmaceuticals, Inc

  • Abbott Laboratories

  • Ardelyx, Inc

  • Synergy Pharmaceuticals

  • Novartis AG

  • Astellas Pharma Inc

  • Valeant Pharmaceuticals International Inc


Recent Development



  • In January, Emmaus Life Sciences has announced the results to be under the preliminary focus. It has been observed the first patient with the company focus has attempted to make the study of the diverticulitis treatment (2020).

  • In 2020, May, Hikma Pharmaceuticals PLC. has launched the Dicyclomine Hydrochloride oral solution for the better treatment of the various inflammatory diagnosis of bowel diseases.


Report Overview


This report mainly includes all the details and it tends to initialize growth along with the better efficiency of the companies with particular management. It states that the driving factors have been interrupted due to the covid 19 situation. The entire analysis is based upon the Covid 19 analysis, regional analysis, market overview, segmentation analysis, market dynamics and it mainly includes the challenges, opportunities, restraints, and drivers. Further, the competitive landscape and the other sections are been presented. Hence, all of the information, that has been collected is from the primary as well as the secondary sources.


By Geographically



  • North America

  • Europe

  • Asia- Pacific

  • Other regions of the world


Segmental Overview


By Type



  • Diverticular bleeding

  • Diverticulosis

  • Diverticulitis


By Treatment



  • Medications

  • Surgery

  • Supportive care

  • Penicillin Antibiotic

  • Antibiotics

  • Dietary Supplements

  • IV fluids


By Diagnosis



  • Barium X-ray

  • CT scan

  • Liver function test

  • Blood test

  • Urine test

  • Ultrasound


By end-user



  • Specialty centers

  • Hospitals

  • Research centers


By Regions



  • North America

  • Europe

  • Asia- Pacific

  • Other regions of the world



Speak to Analyst Ask for Customization